Why Encompass Health Corporation’s (EHC) Stock Is Up 10.25%
As of Thursday, August 06, Encompass Health Corporation’s EHC share price has surged by 10.25%, which has investors questioning if this is right time to sell.Jenna Brashear
Stock Evaluator: Encompass Health Corporation (EHC)
Encompass Health Corporation EHC
$120.31
-0.60
-0.50%
August 21, 2026 4:00:02 PM
EST
Volume: 690,450
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NYSE | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Providers & Services |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. The company offers specialized rehabilitative treatment, using technology and therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence, and quality of life; medical, nursing, therapy, and ancillary services; and rehabilitative care to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. It offers services through the Medicare program to the federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was incorporated in 1984 and is based in Birmingham, Alabama.
Commentary & Analysis
Why Encompass Health Corporation’s (EHC) Stock Is Up 12.95%
As of Thursday, August 06, Encompass Health Corporation’s EHC share price has surged by 12.95%, which has investors questioning if this is right time to sell.Omar Beirat
Which Is a Better Investment, Astrana Health, Inc. or Encompass Health Corporation Stock?
Learn more about whether Astrana Health, Inc. or Encompass Health Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.Tudor Pop
Which Is a Better Investment, Clover Health Investments, Corp. or Encompass Health Corporation Stock?
Learn more about whether Clover Health Investments, Corp. or Encompass Health Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.Tudor Pop
Which Is a Better Investment, Encompass Health Corporation or Elevance Health, Inc. Stock?
Learn more about whether Encompass Health Corporation or Elevance Health, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.Rosalio Madrigal
Financial Summary
| Share Statistics | EHC | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $11,869.0 | $1,968.0 | 79% |
|
| Shares Out (Mil) | 100.0 | 77.7 | 62% |
|
| Institutional Ownership | 99.0% | 86.6% | 84% |
|
| Float (Mil) | 97.6 | 52.1 | 60% |
|
| Beta | 0.60 | 0.75 | 35% |
|
| Avg Daily Volume (000s) | 922 | 612 | 69% |
|
| Price Change (52-week) |
(2.6%) | 79.8% | 42% |
|
| Growth | EHC | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 10.7% | 10.9% | 61% |
|
| Net Income (5yr) | 14.8% | (1.6%) | 63% |
|
| EPS (5yr) | 14.2% | 0.3% | 54 |
|
| Dividends (5yr) | (8.5%) | 0.0% | 74% |
|
| Cash Flow (5yr) | (16.3%) | (17.9%) | 44% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 12 | 13 | 13 | |
| Current EPS | $1.362 | $6.113 | $6.678 | |
| Month Ago EPS | $1.356 | $6.005 | $6.537 | |
| # Rev Up | 1 | 3 | 1 | |
| # Rev Down | 0 | 0 | 0 | |
| Three Months Ago EPS | $1.360 | $6.010 | $6.544 | |
| Year/Year Chg | (11.8%) | 10.1% | 31.0% | |
| Financials | EHC | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $6,206 | $1,504 | 78% |
|
| Net Income (TTM) (Mil) | $621 | $28 | 81% |
|
| EPS (TTM) | $6.213 | $0.200 | 89% |
|
| Operating Cash Flow (TTM) (Mil) | $1,213 | $162 | 83% |
|
| Net Cash Flow (TTM) (Mil) | ($4) | $9 | 35% |
|
| Long-Term Debt (Q1) (Mil) | $2,779 | $338 | 78% |
|
| Enterprise Value (Q1) (Mil) | $15,964 | $2,416 | 80% |
|
| Valuation | EHC | Industry Median |
Percentile (All Stocks) |
|
| P/B | 4.58 | 2.82 | 75% |
|
| P/E | 20.1 | 26.0 | 51% |
|
| Dividend Yield | 0.7% | 0.0% | 64% |
|
| PEG (5yr hist) | 0.9 | 1.1 | 40% |
|
| Ratios | EHC | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 43.9% | 27.8% | 55% |
|
| Net Margin | 10.0% | 1.2% | 63% |
|
| ROA | 8.7% | 2.2% | 84% |
|
| ROE | 25.5% | 7.2% | 84% |
|
| Liabilities to Assets | 53.6% | 58.6% | 46% |
|
| F-Score | 8 | 5 | 93% |
|
Passing Stock Screens
As of 8/21/2026, from a list of 60 stock screening strategies,
GURU STRATEGY
Lakonishok Screen
Factors: Value, Momentum
Identifying stocks trading at a discount to their industry norms but showing recent price strength and upward earnings revisions.
| Performance Since Inception: | 13.2% |
| +/- S&P 500: | +5.7 |
FACTOR STRATEGY
P/E Relative Screen
Factors: Value, Earnings Estimates
A screen that looks at the relationship of a stock's price-earnings ratio to that of the industry and market.
| Performance Since Inception: | 13.7% |
| +/- S&P 500: | +6.2 |
